Award
NIH Reporter #11252227
Preparing IND filing for novel lung cancer therapeutic
Recipient
Not Specified
Award Amount
$249,815.00
Ceiling
$249,815.00
Awarded
August 28, 2025
Identifier
11252227
Award for preparing IND filing for a novel lung cancer therapeutic focusing on inhaled dry powder aerosol formulation, funded by the National Cancer Institute.
Description
This project aims to complete the regulatory data required for IND filing of QM-269 for lung cancer treatment, with a focus on inhaled dry powder aerosol formulation. The project is funded by the NIH and involves the development of targeted therapies with FDA approval pathways.